95
Participants
Start Date
June 30, 2004
Primary Completion Date
July 31, 2007
Study Completion Date
June 30, 2009
Cytarabine
3 g/m2 bid. i.v day 1-3
Mitoxantrone
12 mg/m2 i.v. day 2 and 3
Gemtuzumab Ozogamicin
3mg/m² i.v. day 1
All-trans-Retinoid Acid
45 mg/m2 p.o. day 4-6 15 mg/m2 p.o. day 7-28
Department of Oncology and Hematology, University Hospital Eppendorf, Hamburg
Medical Department II, University Hospital of Kiel, Kiel
Department of Hematology and Oncology, Clinical Center of Oldenburg gGmbH, Oldenburg
Medical Department III, Clinical Center Hannover-Siloah, Hanover
Department of Hematology, Hemostaseology and Oncology, Medizinische Hochschule Hannover, Hanover
Medical Department IV, University Hospital of Gießen, Giessen
Centre of Internal Medicine, University Hospital of Göttingen, Göttingen
Medical Department I, Helios Hospital Wuppertal, Wuppertal
Department of Hematology and Oncology, Hospital Essen-Süd, Ev. Hospital of Essen-Werden, Essen
Department of Internal Medicine, Wilhelm-Anton-Hospital gGmbH, Goch
Department of General Internal Medicine, University Hospital of Bonn, Bonn
Department of Hematology and internal Oncology, University Hospital of Mainz, Mainz
Department of Hematology / Oncology, Clinical center of Lüdenscheid, Lüdenscheid
Medical Department III, Clinical Center Hanau, Hanau
Department of Internal Medicine III, City Hospital Frankfurt am Main - Höchst, Frankfurt
Department of Hematology and Oncology / Caritas Hospital St. Theresia, Saarbrücken
Department of Internal Medicine I, University Hospital of Saarland, Homburg
Department of Internal Medicine / Hematology and Oncology, Caritas Hospital Lebach, Lebach
Department of Oncology / Clinical Center of Stuttgart, Stuttgart
Department of Internal Medicine II, University Hospital of Tübingen, Tübingen
Medical Department II, City Hospital Karlsruhe gGmbH, Karlsruhe
Medical Department III, Clinical Center rechts der Isar, München
Medical Department II, Central Hospital of Augsburg, Augsburg
Department of Internal Medicine III, University of Ulm, Ulm
Department of Hematology / Oncology, University Hospital of Innsbruck, Innsbruck
St. Johann Hospital, Clinical Center of Salzburg, Salzburg
Medical Department III, Hanusch-Hospital, Vienna
University of Ulm
OTHER